Wuhan Neurophth Biotechnology Limited Company
2 clinical trials · Sponsor
◉ Watch Wuhan Neurophth Biotechnology Limited Company
| Record | Firm | Date |
|---|---|---|
| A Phase 3, Multicenter, Randomized, Double-Masked, Sham-Controlled Clinical Trial for Leber's Hereditary Optic Neuropathy (LHON) Associated With ND4 Mutation (NCT07406854) | Wuhan Neurophth Biotechnology Limited Company | 2024-09-19 |
| Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy (NCT04912843) | Wuhan Neurophth Biotechnology Limited Company | 2021-06-18 |
Track Wuhan Neurophth Biotechnology Limited Company automatically
Every clearance here is in the API, with alerts when new ones post.